US Stock MarketDetailed Quotes

4D Molecular Therapeutics (FDMT)

Watchlist
  • 10.450
  • +0.110+1.06%
Close May 13 16:00 ET
  • 10.700
  • +0.250+2.39%
Pre 04:26 ET
546.29MMarket Cap-4.07P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

4D Molecular Therapeutics (FDMT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-42.65%-68.13M
18.95%-109.08M
162.25%28.55M
-58.20%-46.5M
-43.43%-43.38M
-64.18%-47.76M
-77.57%-134.59M
-86.06%-45.86M
-2,409.91%-29.39M
-37.06%-30.24M
Net income from continuing operations
-43.33%-68.76M
12.90%-140.11M
139.05%19.4M
-29.73%-56.88M
-56.38%-54.66M
-48.06%-47.97M
-59.53%-160.87M
-53.86%-49.67M
-327.49%-43.84M
-18.02%-34.95M
Operating gains losses
113.64%12K
-148.60%-52K
-7.14%13K
-69.44%11K
-65.71%12K
-500.00%-88K
-56.33%107K
-36.36%14K
-79.89%36K
133.33%35K
Depreciation and amortization
17.16%2.06M
13.72%7.63M
10.99%1.98M
17.62%2M
16.26%1.89M
10.04%1.75M
16.63%6.71M
17.91%1.78M
21.99%1.7M
13.73%1.62M
Change In working capital
33.75%-4.75M
1,049.35%6.17M
174.10%2.76M
-40.93%5M
912.35%5.59M
-103.72%-7.17M
-14.76%537K
-659.94%-3.72M
173.18%8.46M
-150.63%-688K
-Change in prepaid assets
-271.79%-3.99M
75.04%-424K
-165.74%-3.17M
50.82%2.75M
205.85%1.07M
18.76%-1.07M
-21.44%-1.7M
-634.08%-1.19M
258.85%1.82M
-78.41%-1.01M
-Change in payables and accrued expense
76.84%-590K
101.83%14.93M
837.61%6.67M
-58.60%3.15M
220.73%7.66M
-51.07%-2.55M
73.31%7.4M
-199.45%-904K
52.46%7.6M
13.44%2.39M
-Change in other current assets
75.92%-670K
-37.74%-4.93M
113.75%192K
101.83%10K
-51.61%-2.35M
-3,061.36%-2.78M
-5,010.00%-3.58M
-139,500.00%-1.4M
-689.86%-545K
-1,507.27%-1.55M
-Change in other current liabilities
-16.45%-878K
-93.40%-3.19M
-274.45%-850K
-99.51%-814K
-50.49%-775K
-50.50%-754K
-13.63%-1.65M
53.29%-227K
13.74%-408K
-909.80%-515K
-Change in other working capital
9,957.14%1.38M
-402.90%-209K
---90K
-2,900.00%-90K
-200.00%-15K
-118.18%-14K
109.65%69K
--0
98.47%-3K
97.92%-5K
Cash from discontinued investing activities
Operating cash flow
-42.65%-68.13M
18.95%-109.08M
162.25%28.55M
-58.20%-46.5M
-43.43%-43.38M
-64.18%-47.76M
-77.57%-134.59M
-86.06%-45.86M
-2,409.91%-29.39M
-37.06%-30.24M
Investing cash flow
Cash flow from continuing investing activities
115.63%68.89M
69.26%-92.97M
-1,925.29%-128.85M
-34.88%17.78M
81.16%-13.85M
112.14%31.95M
-361.36%-302.44M
205.64%7.06M
-8.94%27.3M
-249.20%-73.54M
Net PPE purchase and sale
101.74%11K
85.84%-536K
107.38%70K
105.12%91K
81.09%-66K
11.13%-631K
-36.63%-3.79M
-72.86%-949K
-339.01%-1.78M
56.65%-349K
Net investment purchase and sale
111.42%68.88M
69.05%-92.44M
-1,709.85%-128.92M
-39.18%17.69M
81.16%-13.79M
112.41%32.58M
-352.05%-298.65M
230.57%8.01M
-4.30%29.08M
-246.11%-73.19M
Cash from discontinued investing activities
Investing cash flow
115.63%68.89M
69.26%-92.97M
-1,925.29%-128.85M
-34.88%17.78M
81.16%-13.85M
112.14%31.95M
-361.36%-302.44M
205.64%7.06M
-8.94%27.3M
-249.20%-73.54M
Financing cash flow
Cash flow from continuing financing activities
11.48M
-66.51%112.96M
18,532.61%111.98M
-79.58%116K
-95.00%862K
0
115.04%337.25M
-87.38%601K
-94.62%568K
-86.78%17.25M
Net common stock issuance
--9.81M
-66.59%110.72M
--110.72M
--0
--0
--0
123.41%331.41M
--0
-99.99%1K
-87.90%15.69M
Proceeds from stock option exercised by employees
--1.67M
-61.68%2.24M
109.48%1.26M
-79.54%116K
-44.64%862K
--0
-31.22%5.84M
-87.38%601K
-45.48%567K
22.50%1.56M
Cash from discontinued financing activities
Financing cash flow
--11.48M
-66.51%112.96M
18,532.61%111.98M
-79.58%116K
-95.00%862K
--0
115.04%337.25M
-87.38%601K
-94.62%568K
-86.78%17.25M
Net cash flow
Beginning cash position
-59.66%60.24M
-40.05%149.34M
-74.11%48.56M
-59.19%77.16M
-51.55%133.53M
-40.05%149.34M
375.84%249.11M
-31.97%187.54M
-19.99%189.06M
250.77%275.59M
Current changes in cash
177.46%12.25M
10.70%-89.1M
130.59%11.69M
-1,779.37%-28.6M
34.86%-56.37M
-159.69%-15.81M
-150.71%-99.77M
-43.78%-38.2M
-103.87%-1.52M
-154.86%-86.53M
End cash Position
-45.71%72.49M
-59.66%60.24M
-59.66%60.24M
-74.11%48.56M
-59.19%77.16M
-51.55%133.53M
-40.05%149.34M
-40.05%149.34M
-31.97%187.54M
-19.99%189.06M
Free cash flow
-40.79%-68.13M
20.78%-109.62M
161.14%28.62M
-48.89%-46.41M
-42.01%-43.44M
-62.39%-48.39M
-76.13%-138.37M
-85.77%-46.81M
-1,877.73%-31.17M
-33.76%-30.59M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -42.65%-68.13M18.95%-109.08M162.25%28.55M-58.20%-46.5M-43.43%-43.38M-64.18%-47.76M-77.57%-134.59M-86.06%-45.86M-2,409.91%-29.39M-37.06%-30.24M
Net income from continuing operations -43.33%-68.76M12.90%-140.11M139.05%19.4M-29.73%-56.88M-56.38%-54.66M-48.06%-47.97M-59.53%-160.87M-53.86%-49.67M-327.49%-43.84M-18.02%-34.95M
Operating gains losses 113.64%12K-148.60%-52K-7.14%13K-69.44%11K-65.71%12K-500.00%-88K-56.33%107K-36.36%14K-79.89%36K133.33%35K
Depreciation and amortization 17.16%2.06M13.72%7.63M10.99%1.98M17.62%2M16.26%1.89M10.04%1.75M16.63%6.71M17.91%1.78M21.99%1.7M13.73%1.62M
Change In working capital 33.75%-4.75M1,049.35%6.17M174.10%2.76M-40.93%5M912.35%5.59M-103.72%-7.17M-14.76%537K-659.94%-3.72M173.18%8.46M-150.63%-688K
-Change in prepaid assets -271.79%-3.99M75.04%-424K-165.74%-3.17M50.82%2.75M205.85%1.07M18.76%-1.07M-21.44%-1.7M-634.08%-1.19M258.85%1.82M-78.41%-1.01M
-Change in payables and accrued expense 76.84%-590K101.83%14.93M837.61%6.67M-58.60%3.15M220.73%7.66M-51.07%-2.55M73.31%7.4M-199.45%-904K52.46%7.6M13.44%2.39M
-Change in other current assets 75.92%-670K-37.74%-4.93M113.75%192K101.83%10K-51.61%-2.35M-3,061.36%-2.78M-5,010.00%-3.58M-139,500.00%-1.4M-689.86%-545K-1,507.27%-1.55M
-Change in other current liabilities -16.45%-878K-93.40%-3.19M-274.45%-850K-99.51%-814K-50.49%-775K-50.50%-754K-13.63%-1.65M53.29%-227K13.74%-408K-909.80%-515K
-Change in other working capital 9,957.14%1.38M-402.90%-209K---90K-2,900.00%-90K-200.00%-15K-118.18%-14K109.65%69K--098.47%-3K97.92%-5K
Cash from discontinued investing activities
Operating cash flow -42.65%-68.13M18.95%-109.08M162.25%28.55M-58.20%-46.5M-43.43%-43.38M-64.18%-47.76M-77.57%-134.59M-86.06%-45.86M-2,409.91%-29.39M-37.06%-30.24M
Investing cash flow
Cash flow from continuing investing activities 115.63%68.89M69.26%-92.97M-1,925.29%-128.85M-34.88%17.78M81.16%-13.85M112.14%31.95M-361.36%-302.44M205.64%7.06M-8.94%27.3M-249.20%-73.54M
Net PPE purchase and sale 101.74%11K85.84%-536K107.38%70K105.12%91K81.09%-66K11.13%-631K-36.63%-3.79M-72.86%-949K-339.01%-1.78M56.65%-349K
Net investment purchase and sale 111.42%68.88M69.05%-92.44M-1,709.85%-128.92M-39.18%17.69M81.16%-13.79M112.41%32.58M-352.05%-298.65M230.57%8.01M-4.30%29.08M-246.11%-73.19M
Cash from discontinued investing activities
Investing cash flow 115.63%68.89M69.26%-92.97M-1,925.29%-128.85M-34.88%17.78M81.16%-13.85M112.14%31.95M-361.36%-302.44M205.64%7.06M-8.94%27.3M-249.20%-73.54M
Financing cash flow
Cash flow from continuing financing activities 11.48M-66.51%112.96M18,532.61%111.98M-79.58%116K-95.00%862K0115.04%337.25M-87.38%601K-94.62%568K-86.78%17.25M
Net common stock issuance --9.81M-66.59%110.72M--110.72M--0--0--0123.41%331.41M--0-99.99%1K-87.90%15.69M
Proceeds from stock option exercised by employees --1.67M-61.68%2.24M109.48%1.26M-79.54%116K-44.64%862K--0-31.22%5.84M-87.38%601K-45.48%567K22.50%1.56M
Cash from discontinued financing activities
Financing cash flow --11.48M-66.51%112.96M18,532.61%111.98M-79.58%116K-95.00%862K--0115.04%337.25M-87.38%601K-94.62%568K-86.78%17.25M
Net cash flow
Beginning cash position -59.66%60.24M-40.05%149.34M-74.11%48.56M-59.19%77.16M-51.55%133.53M-40.05%149.34M375.84%249.11M-31.97%187.54M-19.99%189.06M250.77%275.59M
Current changes in cash 177.46%12.25M10.70%-89.1M130.59%11.69M-1,779.37%-28.6M34.86%-56.37M-159.69%-15.81M-150.71%-99.77M-43.78%-38.2M-103.87%-1.52M-154.86%-86.53M
End cash Position -45.71%72.49M-59.66%60.24M-59.66%60.24M-74.11%48.56M-59.19%77.16M-51.55%133.53M-40.05%149.34M-40.05%149.34M-31.97%187.54M-19.99%189.06M
Free cash flow -40.79%-68.13M20.78%-109.62M161.14%28.62M-48.89%-46.41M-42.01%-43.44M-62.39%-48.39M-76.13%-138.37M-85.77%-46.81M-1,877.73%-31.17M-33.76%-30.59M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -